Uni-Bio Science Group Ltd. Stock: price and insider trades · Hong Kong
1 insider bought €35k of shares over the last 90 days, the latest by ZHAO ZHI GANG, filed 06 Oct 2026.
Uni-Bio Science Group Ltd.: what insiders have been doing
Uni-Bio Science Group Ltd. is a Health Care company. Its directors and officers file their transactions with HKEX. Over the twelve months to 31 October 2026, 8 filings were filed, from 4 insiders.
The record shows 4 purchases on the open market worth €2.5M, made by 3 insiders, against 4 sales worth €20.9M by 3 insiders. The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. At €20.6M, the sale published on 8 April 2026 by Leung Kingsley is the largest of the period. Among those who bought: 3 senior executives.
In all, 3 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last insider purchase was made public on 6 October 2026, 33 days ago. Between a trade and the moment it shows up on HKEX, the median delay is 5 days. Until a filing is published, the market cannot know about the trade.
Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 8 filings, this issuer sits above that mark. Over the whole record (from 2018), the tally stands at 18 purchases and 24 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -8.5%Entry HK$0.07 · Close 29 Oct 2026 HK$0.06
- -25.3%Entry HK$0.09 · Close 29 Oct 2026 HK$0.06
- -25.3%Entry HK$0.09 · Close 29 Oct 2026 HK$0.06
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,780,000 shares@ HK$0.17140.072% mcap100.0% of flowShareXHKGHKEX:DA20261006E00072
- 1,780,000 shares@ HK$0.17140.072% mcap3.5% of flowShareXHKGHKEX:DA20261006E00052Canonical exit: 4 Jan 2027 (T+90)
- 90,000,000 shares@ HK$0.092.64% mcap4.2% of flowShareXHKGHKEX:DA20260629E00005Canonical exit: 22 Sept 2026 (T+90)
- 60,000,000 shares@ HK$0.091.76% mcap100.0% of flowShareXHKGHKEX:DA20260629E00007Canonical exit: 22 Sept 2026 (T+90)
- 90,000,000 shares@ HK$0.092.64% mcap100.0% of flowShareXHKGHKEX:DA20260629E00031Canonical exit: 22 Sept 2026 (T+90)
- 30,000,000 shares@ HK$0.0970.93% mcap1.5% of flowShareXHKGHKEX:DA20260408E00095
- 1,550,971,464 shares@ HK$0.11959.51% mcap94.3% of flowShareXHKGHKEX:DA20260402E00549
- 1,940,000 sharesShareXHKGHKEX:DA20260126E00062
- 3,020,000 sharesShareXHKGHKEX:DA20250709E00011
- 1,160,000 sharesShareXHKGHKEX:DA20250709E00015
- 80,000,000 shares@ HK$0.0822.8% of flowShareXHKGHKEX:DA20250527E00446Canonical exit: 25 Aug 2025 (T+90)
- 59,420,000 shares@ HK$0.0751.9% of flowShareXHKGHKEX:DA20250519E00395Canonical exit: 4 Aug 2025 (T+90)
- 560,000 sharesShareXHKGHKEX:DA20250122E00030
- 178,893,000 sharesShareXHKGHKEX:DA20241217E00204
- 50,000,000 sharesShareXHKGHKEX:DA20241104E00039Canonical exit: 30 Jan 2025 (T+90)
- 282,520,000 shares@ HK$0.001100.0% of flowShareXHKGHKEX:DA20241011E00295
- 282,520,000 shares@ HK$0.0010.2% of flowShareXHKGHKEX:DA20241011E00294
- 1,560,000 sharesShareXHKGHKEX:DA20240911E00033
- 2,940,000 sharesShareXHKGHKEX:DA20240911E00032
- 481,890,000 shares@ HK$0.06321.8% of flowShareXHKGHKEX:DA20240627E00031
- 218,340,000 shares0ShareXHKGHKEX:DA20240617E00013
- 95,861,078 shares@ HK$0.0954.4% of flowShareXHKGHKEX:DA20220916E00265
- 7,000,000 sharesShareXHKGHKEX:DA20220414E00517
- 1,400,000 sharesShareXHKGHKEX:DA20220414E00539Canonical exit: 13 Jul 2022 (T+90)
- 15,000,000 sharesShareXHKGHKEX:DA20220411E00379
25 of 49 declarations
About Uni-Bio Science Group Ltd.
Uni-Bio Science Group Ltd. is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical products. It is listed on the Hong Kong Stock Exchange (XHKG).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
